Position in NVCR
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$32,168,481
+$30,347,771 QoQ
Shares Held
2,951,237
+1995.9% QoQ
Ownership
2.55%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.53748207954834.ToString("F0")%
Shared 0.ToString("F0")%
None 0.46251792045166146.ToString("F0")%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Derivatives in NVCR
reported options exposure · as of Mar 31, 2026CallValue
$1,853,000
CallShares
170,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $3,733,776,546 across 105 Medical Devices names. NVCR ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
15,909,341 | $1,633,412,039 | |
| 2 | SYK |
Stryker Corp
|
2,297,196 | $754,835,631 | |
| 3 | MDT |
Medtronic plc
|
7,514,778 | $651,155,511 | |
| 4 | BSX |
Boston Scientific Corp
|
2,971,322 | $186,450,453 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,081,271 | $86,588,179 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
1,150,789 | $81,913,158 | |
| 7 | DXCM |
Dexcom Inc
|
845,998 | $53,128,672 | |
| 8 | NVCR |
NovoCure Ltd
This page
|
2,951,237 | $32,168,481 |
All Filings in NVCR
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,853,000 | 170,000 | Call | Defined | 2026-05-11 | |
| 2026-03-31 | $32,168,481 | 2,951,237 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $2,198,100 | 170,000 | Call | Defined | 2026-02-13 | |
| 2025-12-31 | $1,820,710 | 140,813 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $646,000 | 50,000 | Call | Defined | 2025-11-13 | |
| 2025-09-30 | $1,074,916 | 83,198 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,003,620 | 112,563 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $890,000 | 50,000 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $1,823,769 | 102,344 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $891,000 | 50,000 | Call | Defined | 2025-05-13 | |
| 2024-12-31 | $2,178,320 | 73,098 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $576,527 | 36,886 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,862,916 | 225,506 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $435,950 | 27,892 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $251,539 | 16,848 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $355,686 | 22,024 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,029,116 | 24,798 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,870,412 | 31,101 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $366,750 | 5,000 | Put | Defined | 2023-02-13 | |
| 2022-12-31 | $4,221,291 | 57,550 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,460,480 | 58,706 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,176,463 | 60,093 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,292,870 | 63,885 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,293,448 | 57,185 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,590,993 | 82,560 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $130,161,089 | 586,787 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $131,603,825 | 995,641 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $197,487,263 | 1,141,281 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $120,941,096 | 1,086,525 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $80,478,223 | 1,357,137 | Shares | Defined | 2020-08-13 | |
| 2020-06-30 | $2,122,940 | 35,800 | Call | Defined | 2020-08-13 | |
| 2020-03-31 | $2,410,772 | 35,800 | Call | Defined | 2020-05-14 | |
| 2020-03-31 | $78,701,872 | 1,168,724 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||